-

International Myeloma Workshop (IMW) 2019

Oncopeptides to present:

 

Two Poster presentations
– Quality of life of treatment for relapsed/refractory multiple myeloma: a systematic review

– Aminopeptidase gene expression in myeloma
And

 

Oral late breaker presentation by Paul G Richardson – Title: Melflufen in Relapsed/Refractory MM in Phase 2 Horizon Study: Promising Results in High Risk Population

Upcoming events

Annual General Meeting 2022

The Annual General Meeting in Oncopeptides AB (publ) will be held on Tuesday June 28, 2022, (changed from May 19, 2022) in Stockholm, Sweden. Due to the extraordinary situation resulting from the covid-19 pandemic, Oncopeptides’ Annual General Meeting will be carried out through advance voting (postal voting) pursuant to temporary legislation. No meeting with the possibility to attend in person or to be represented by a proxy will take place. Hence, the Annual General Meeting will be held without physical presence.

Silent Period

-

Silent Period

-

Silent Period

-

Year-end report 2022

08:00 CET